Brief: Perspective Therapeutics And GT Medical Technologies Collaborate To Expand Access To Unique Cesium-131 Based Brain Cancer Treatment
09/08/2023 15:08
Aug 9 (Reuters) - Perspective Therapeutics Inc CATX.A :
* PERSPECTIVE THERAPEUTICS AND GT MEDICAL TECHNOLOGIES
COLLABORATE
TO EXPAND ACCESS TO UNIQUE CESIUM-131 BASED BRAIN CANCER
TREATMENT
Source text for Eikon: ID:nGNX30CKkp
Further company coverage: CATX.A
Recent news on Perspective Therapeutics
See all newsPerspective Therapeutics Q2 net loss widens on higher R&D costs
Brief: Perspective Therapeutics Q2 EPS USD -0.22
Brief: Perspective Therapeutics Expands Therapeutic Focus Areas First Patient Dosed With Vmt-Α-Net In The Meningioma Cohort Of A Phase 1/2A Study
Brief: Perspective Therapeutics Q1 EPS USD -0.25
Perspective Therapeutics rises as experimental cancer drug shows promise